AAAAAA
Results: 151-175/1811
Authors:
PARDRIDGE WM
WU DF
SAKANE T
Citation: Wm. Pardridge et al., COMBINED USE OF CARBOXYL-DIRECTED PROTEIN PEGYLATION AND VECTOR-MEDIATED BLOOD-BRAIN-BARRIER DRUG-DELIVERY SYSTEM OPTIMIZES BRAIN UPTAKE OFBRAIN-DERIVED NEUROTROPHIC FACTOR FOLLOWING INTRAVENOUS ADMINISTRATION, Pharmaceutical research, 15(4), 1998, pp. 576-582
Authors:
NICKLIN PL
BAYLEY D
GIDDINGS J
CRAIG SJ
CUMMINS LL
HASTEWELL JG
PHILLIPS JA
Citation: Pl. Nicklin et al., PULMONARY BIOAVAILABILITY OF A PHOSPHOROTHIOATE OLIGONUCLEOTIDE (CGP 64128A) - COMPARISON WITH OTHER DELIVERY ROUTES, Pharmaceutical research, 15(4), 1998, pp. 583-591
Authors:
KOSA T
MARUYAMA T
SAKAI N
YONEMURA N
YAHARA S
OTAGIRI M
Citation: T. Kosa et al., SPECIES-DIFFERENCES OF SERUM ALBUMINS - III - ANALYSIS OF STRUCTURAL CHARACTERISTICS AND LIGAND-BINDING PROPERTIES DURING N-B TRANSITIONS, Pharmaceutical research, 15(4), 1998, pp. 592-598
Authors:
LETRENT SP
POLLACK GM
BROUWER KR
BROUWER KLR
Citation: Sp. Letrent et al., EFFECT OF GF120918, A POTENT P-GLYCOPROTEIN INHIBITOR, ON MORPHINE PHARMACOKINETICS AND PHARMACODYNAMICS IN THE RAT, Pharmaceutical research, 15(4), 1998, pp. 599-605
Authors:
COHEN H
SOLOMON V
ALFERIEV IS
BREUER E
ORNOY A
PATLAS N
EIDELMAN N
HAGELE G
GOLOMB G
Citation: H. Cohen et al., BISPHOSPHONATES AND TETRACYCLINE - EXPERIMENTAL-MODELS FOR THEIR EVALUATION IN CALCIUM-RELATED DISORDERS, Pharmaceutical research, 15(4), 1998, pp. 606-613
Authors:
AUCLAIR B
SIROIS G
NGOC AH
DUCHARME MP
Citation: B. Auclair et al., NOVEL PHARMACOKINETIC MODELING OF TRANSDERMAL NITROGLYCERIN, Pharmaceutical research, 15(4), 1998, pp. 614-619
Authors:
OGIHARA T
TAMAI I
TSUJI A
Citation: T. Ogihara et al., APPLICATION OF FRACTAL KINETICS FOR CARRIER-MEDIATED TRANSPORT OF DRUGS ACROSS INTESTINAL EPITHELIAL MEMBRANE, Pharmaceutical research, 15(4), 1998, pp. 620-625
Authors:
YOSHIGAE Y
IMAI T
HORITA A
MATSUKANE H
OTAGIRI M
Citation: Y. Yoshigae et al., SPECIES-DIFFERENCES IN STEREOSELECTIVE HYDROLASE ACTIVITY IN INTESTINAL-MUCOSA, Pharmaceutical research, 15(4), 1998, pp. 626-631
Authors:
LIU JL
LU KV
ERIS T
KATTA V
WESTCOTT KR
NARHI LO
LU HS
Citation: Jl. Liu et al., IN-VITRO METHIONINE OXIDATION OF RECOMBINANT HUMAN LEPTIN, Pharmaceutical research, 15(4), 1998, pp. 632-640
Authors:
RUNKEL L
MEIER W
PEPINSKY RB
KARPUSAS M
WHITTY A
KIMBALL K
BRICKELMAIER M
MULDOWNEY C
JONES W
GOELZ SE
Citation: L. Runkel et al., STRUCTURAL AND FUNCTIONAL DIFFERENCES BETWEEN GLYCOSYLATED AND NONGLYCOSYLATED FORMS OF HUMAN INTERFERON-BETA (IFN-BETA), Pharmaceutical research, 15(4), 1998, pp. 641-649
Authors:
HEKMAN C
DEMOND W
DIXIT T
MAUCH S
NUECHTERLEIN M
STEPANENKO A
WILLIAMS JD
YE M
Citation: C. Hekman et al., ISOLATION AND IDENTIFICATION OF PEPTIDE DEGRADATION PRODUCTS OF HEAT-STRESSED PRAMLINTIDE INJECTION-DRUG PRODUCT, Pharmaceutical research, 15(4), 1998, pp. 650-659
Authors:
ROBINSON JR
Citation: Jr. Robinson, AN INTERVIEW WITH A DISTINGUISHED PHARMACEUTICAL SCIENTIST - ROBINSON,JOSEPH,R, Pharmaceutical research, 15(3), 1998, pp. 365-367
Authors:
KOLLMAN P
Citation: P. Kollman, RECENT ADVANCES IN STRUCTURE-BASED LIGAND DESIGN USING MOLECULAR-DYNAMICS AND MONTE-CARLO METHODS, Pharmaceutical research, 15(3), 1998, pp. 368-370
Authors:
ARIMORI K
NAKANO M
Citation: K. Arimori et M. Nakano, DRUG EXSORPTION FROM BLOOD INTO THE GASTROINTESTINAL-TRACT, Pharmaceutical research, 15(3), 1998, pp. 371-376
Authors:
HALLER MF
SALTZMAN WM
Citation: Mf. Haller et Wm. Saltzman, LOCALIZED DELIVERY OF PROTEINS IN THE BRAIN - CAN TRANSPORT BE CUSTOMIZED, Pharmaceutical research, 15(3), 1998, pp. 377-385
Authors:
BRINTON RD
YAMAZAKI RS
Citation: Rd. Brinton et Rs. Yamazaki, ADVANCES AND CHALLENGES IN THE PREVENTION AND TREATMENT OF ALZHEIMERS-DISEASE, Pharmaceutical research, 15(3), 1998, pp. 386-398
Authors:
ENDRENYI L
CSIZMADIA F
TOTHFALUSI L
BALCH AH
CHEN ML
Citation: L. Endrenyi et al., THE DURATION OF MEASURING PARTIAL AUCS FOR THE ASSESSMENT OF BIOEQUIVALENCE, Pharmaceutical research, 15(3), 1998, pp. 399-404
Authors:
BONATE PL
Citation: Pl. Bonate, COVERAGE AND PRECISION OF CONFIDENCE-INTERVALS FOR AREA-UNDER-THE-CURVE USING PARAMETRIC AND NONPARAMETRIC METHODS IN A TOXICOKINETIC EXPERIMENTAL-DESIGN, Pharmaceutical research, 15(3), 1998, pp. 405-410
Authors:
YABUUCHI H
TAMAI I
SAI Y
TSUJI A
Citation: H. Yabuuchi et al., POSSIBLE ROLE OF ANION-EXCHANGER AE2 AS THE INTESTINAL MONOCARBOXYLICACID ANION ANTIPORTER, Pharmaceutical research, 15(3), 1998, pp. 411-416
Authors:
KENYON CJ
BROWN F
MCCLELLAND GR
WILDING IR
Citation: Cj. Kenyon et al., THE USE OF PHARMACOSCINTIGRAPHY TO ELUCIDATE FOOD EFFECTS OBSERVED WITH A NOVEL PROTEASE INHIBITOR (SAQUINAVIR), Pharmaceutical research, 15(3), 1998, pp. 417-422
Authors:
ALSENZ J
STEFFEN H
ALEX R
Citation: J. Alsenz et al., ACTIVE APICAL SECRETORY EFFLUX OF THE HIV PROTEASE INHIBITORS SAQUINAVIR AND RITONAVIR IN CACO-2 CELL MONOLAYERS, Pharmaceutical research, 15(3), 1998, pp. 423-428
Authors:
COOK CS
ZHANG LM
OSIS J
SCHOENHARD GL
KARIM A
Citation: Cs. Cook et al., MECHANISM OF COMPOUND-SPECIFIC AND SPECIES-SPECIFIC FOOD EFFECTS OF STRUCTURALLY RELATED ANTIARRHYTHMIC DRUGS, DISOPYRAMIDE AND BIDISOMIDE, Pharmaceutical research, 15(3), 1998, pp. 429-433
Authors:
SHAHROKH Z
LEE E
OLIVERO AG
MATAMOROS RA
ROBARGE KD
LEE A
WEISE KJ
BLACKBURN BK
POWELL MF
Citation: Z. Shahrokh et al., STABILITY OF ALKOXYCARBONYLAMIDINE PRODRUGS, Pharmaceutical research, 15(3), 1998, pp. 434-441
Authors:
COX EH
KNIBBE CAJ
KOSTER VS
LANGEMEIJER MWE
TUKKER EE
LANGE R
KUKS PFM
LANGEMEIJER HJM
LIEAHUEN L
DANHOF M
Citation: Eh. Cox et al., INFLUENCE OF DIFFERENT FAT EMULSION-BASED INTRAVENOUS FORMULATIONS ONTHE PHARMACOKINETICS AND PHARMACODYNAMICS OF PROPOFOL, Pharmaceutical research, 15(3), 1998, pp. 442-448
Authors:
KOSA T
MARUYAMA T
OTAGIRI M
Citation: T. Kosa et al., SPECIES-DIFFERENCES OF SERUM ALBUMINS - II - CHEMICAL AND THERMAL-STABILITY, Pharmaceutical research, 15(3), 1998, pp. 449-454